It's a simple blood draw, called liquid biopsy, and it's an investigation that allows the detection and analysis of ...

Delfi Diagnostics has announced key data and the clinical trial design for its liquid biopsy test to help screen for lung ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they ...

Liquid biopsy has emerged as a revolutionary tool for clinical trials, offering cellular and cell-free methods that provide valuable insights into disease progression and treatment response.

The father of noninvasive prenatal diagnosis and pioneer of the liquid biopsy in detecting cancer has changed the way that ...

The “incredibly exciting” discovery that a new blood test can predict the likelihood of breast cancer recurrence three years ...

Precede Bio’s liquid biopsy assay could help to guide treatment options for patients with HER2 or ER+ cancers.

Mursla Bio’s breakthrough technology for the analysis of extracellular vesicles (EV) sub-types within biofluids such as blood showcased in iScience.

The “liquid biopsy” uses whole genome sequencing to look for genetic faults in a patient’s DNA, which can be a sign of cancer. A team of researchers from the Institute of Cancer Research (ICR), London ...

Predicine, Inc. A leading precision oncology company, announced today that it will present data from 9 ctDNA studies at ASCO 2024, spotlighting the clinical utility of Predicine’s genomic and ...

Company expands leadership in liquid biopsy comprehensive genomic profiling for solid tumors with the integration of OmniSeq® INSIGHT circulating tumor DNA BURLINGTON, N.C., June 3, 2024 /PRNewswire/ ...

A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast ...